Patents by Inventor Uday Kumar

Uday Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8938379
    Abstract: Certain embodiments of the invention may include systems, methods, and apparatus for predicting impact on a pipeline delivery infrastructure. According to an example embodiment of the invention, a method is provided that can include simulating a pipeline delivery infrastructure; identifying one or more sections in the infrastructure; and forecasting an impact of the infrastructure based on one or more modifications to the infrastructure or on one or more new demand points wherein the forecasting comprises estimating pressures in each of identified one or more sections.
    Type: Grant
    Filed: July 29, 2011
    Date of Patent: January 20, 2015
    Assignee: General Electric Company
    Inventors: Kavitha Andoji, Uday Kumar Dubasi, Ganesh Kumar Somesula
  • Publication number: 20150006966
    Abstract: In some implementations, a testing service receives a test execution request for executing test operations on a test target. The testing service may map the test execution request to a particular type of supported test framework from among a plurality of types of supported test frameworks. The testing service may obtain a test package provided by a user that requested the testing, such as from a cloud storage location. The testing service determines a computing capacity for executing the testing and appropriates a plurality of workers in a cloud computing service. The testing service configures the plurality of workers for executing the test operations based on at least one of the test framework, the test execution request or the test package. The testing service provides test execution chunks from the test package to the plurality of workers for executing the testing on the test target.
    Type: Application
    Filed: September 15, 2014
    Publication date: January 1, 2015
    Applicant: Amazon Technologies, Inc.
    Inventors: SLAVIK DIMITROVICH, VENKATA UDAY KUMAR KALEPALLI NAGA, SIAMAK IRANTASH, MICHAEL L. COLLADO, VIJAY P. SINGH, MIKE C. MOORE
  • Patent number: 8918101
    Abstract: An apparatus and method for controlling access to a dual stack architecture using attention (AT) commands including establishing a first subscription to a first network; establishing a second subscription to a second network; selecting a desired subscription from the first subscription and second subscription; and sending an attention (AT) command to direct at least one of a plurality of existing attention (AT) commands towards the desired subscription.
    Type: Grant
    Filed: March 16, 2011
    Date of Patent: December 23, 2014
    Assignee: Qualcomm Incorporated
    Inventors: Uday Kumar Arava, Simi Anand Sathy, Nagarjuna Reddy Chaganti, Bhavik Kirit Shah
  • Publication number: 20140315734
    Abstract: The invention encompasses diagnosis and prognosis in the context of heart or renal failure, particularly in subjects who exhibit a normal body fluid level of a natriuretic peptide. The invention also relates to methods of assigning an increased likelihood that a subject having AKI is susceptible to AKI progression. The invention relates in part to assigning a diagnosis of heart and/or renal failure, and/or an outcome risk (e.g., worsening cardiac and/or renal function or a mortality risk) to a subject based, at least in part, on the result(s) obtained from an assay that detects WAP four-disulfide core domain protein 2 performed on a body fluid sample obtained from a subject.
    Type: Application
    Filed: July 3, 2012
    Publication date: October 23, 2014
    Applicant: ALERE SAN DIEGO INC.
    Inventors: William D. Arnold, Christelle Jost, Brian Noland, Jonathan Gary, Joseph Buechler, Vance Wong, Scott Harold Rongey, Uday Kumar Veeramallu, Kelline Marie Rodems
  • Patent number: 8839035
    Abstract: In some implementations, a testing service receives a test execution request for executing test operations on a test target. The testing service may map the test execution request to a particular type of supported test framework from among a plurality of types of supported test frameworks. The testing service may obtain a test package provided by a user that requested the testing, such as from a cloud storage location. The testing service determines a computing capacity for executing the testing and appropriates a plurality of workers in a cloud computing service. The testing service configures the plurality of workers for executing the test operations based on at least one of the test framework, the test execution request or the test package. The testing service provides test execution chunks from the test package to the plurality of workers for executing the testing on the test target.
    Type: Grant
    Filed: September 14, 2011
    Date of Patent: September 16, 2014
    Assignee: Amazon Technologies, Inc.
    Inventors: Slavik Dimitrovich, Venkata Uday Kumar Kalepalli Naga, Siamak Irantash, Michael L Collado, Vijay P Singh, Michael C. Moore
  • Publication number: 20140243412
    Abstract: Aspects of the present invention relate to improved process for preparation of (R)(?)-3-(carbamoylmethyl)-5-methylhexanoic acid (R-CMHA) of the formula (II) or its pharmaceutically acceptable salts in the presence of a lewis acid, process for preparation of pregabalin using R-CMHA of the formula (II) or its pharmaceutically acceptable salts prepared according to the present invention and process for preparation of pregabalin with low amount of undesired impurity.
    Type: Application
    Filed: February 27, 2014
    Publication date: August 28, 2014
    Applicant: Dr. Reddy's Laboratories Ltd.
    Inventors: Srinivas GANGULA, Uday Kumar NEELAM, Krishna VINIGARI, Vilas Hareshwar DAHANUKAR, Syam Kumar Unniaran KUNHIMON, Srinivas Reddy GADE
  • Patent number: 8795975
    Abstract: The present invention relates in part to diagnosing the occurrence of heart failure, particularly in subjects who exhibit a normal body fluid level of a natriuretic peptide. The present invention further relates in part to assigning an outcome risk (e.g., worsening cardiac function or a mortality risk, a risk of rehospitalization) to a subject. The methods comprise performing one or more assays that detect one or more biomarkers selected from the group consisting of WAP4C, ESAM, LTBR, Mesothelin, and Syndecan-1 performed on a body fluid sample obtained from a subject, and assigning diagnosis or risk based, at least in part, on the result(s) obtained thereby.
    Type: Grant
    Filed: November 25, 2011
    Date of Patent: August 5, 2014
    Assignee: Alere San Diego, Inc.
    Inventors: William D. Arnold, Christelle Jost, Brian Noland, Jonathan Gary, Joseph Buechler, Vance Wong, Scott Harold Rongey, Uday Kumar Veeramallu, Kelline Marie Rodems
  • Publication number: 20140201000
    Abstract: In an example embodiment disclosed herein is an apparatus comprising an interface and mobile billboard logic that is coupled with the interface and operable to communicate with an associated device via the interface. The mobile billboard logic obtains location data for the associated device. The mobile billboard logic determines whether a predetermined trigger condition has been met. The mobile billboard logic selectively sends data representative of an advertisement to the associated device to be displayed on a web page being requested by the associated device based on the location of the associated device and whether the predetermined condition has been met.
    Type: Application
    Filed: January 14, 2013
    Publication date: July 17, 2014
    Applicant: Cisco Technology, Inc.
    Inventors: Ravi AKIREDDY, Esteban Raul TORRES, Robert J. FRIDAY, Sujai HAJELA, Uday Kumar PYDA
  • Publication number: 20140147867
    Abstract: The present invention relates in part to diagnosing the occurrence of heart failure, particularly in subjects who exhibit a normal body fluid level of a natriuretic peptide. The present invention further relates in part to assigning an outcome risk (e.g., worsening cardiac function or a mortality risk, a risk of rehospitalization) to a subject. The methods comprise performing one or more assays that detect one or more biomarkers selected from the group consisting of WAP4C, ESAM, LTBR, Mesothelin, and Syndecan-1 performed on a body fluid sample obtained from a subject, and assigning diagnosis or risk based, at least in part, on the result(s) obtained thereby.
    Type: Application
    Filed: November 25, 2011
    Publication date: May 29, 2014
    Applicant: ALERE SAN DIEGO, INC.
    Inventors: William D. Arnold, Christelle Jost, Brian Noland, Jonathan Gary, Joseph Buechler, Vance Wong, Scott Harold Rongey, Uday Kumar Veeramallu, Kelline Marie Rodems
  • Patent number: 8584103
    Abstract: An example embodiment disclosed is a method for reducing parallelism of computer source code. The method includes receiving multi-threaded program source code and representing the multi-threaded program source code as a polyhedral framework stored in computer readable memory. The polyhedral framework is used to convert the polyhedral framework from the multi-threaded program source code representation to a single-threaded program source code representation.
    Type: Grant
    Filed: June 17, 2010
    Date of Patent: November 12, 2013
    Assignee: International Business Machines Corporation
    Inventors: Uday Kumar Bondhugula, Alexandre E. Eichenberger, John Kevin P. O'Brien, Lakshminarayanan Renganarayana, Yuan Zhao
  • Patent number: 8563535
    Abstract: An aqueous gel composition of the present invention comprising about 0.1 to 0.3 wt % adapalene and about 2.5 to 5.0 wt % benzoyl peroxide, as active ingredients, wherein both the active ingredients are stabilized in hydrophilic gelling matrix of pH dependent gelling agent comprising crosslinked, acrylic acid-based polymer(s).
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: October 22, 2013
    Inventors: Kamal Mehta, Lalatendu Panigrahi, Uday Kumar Nayak, Balakrishna Patro
  • Patent number: 8476040
    Abstract: The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: July 2, 2013
    Assignee: Xoma Technology Ltd.
    Inventors: Jeff Gray, Joe Buechler, Uday Kumar Veeramallu
  • Patent number: 8370229
    Abstract: The present invention provides an improved billing and contract management method and a computerized enterprise resource management system for processing and management of rent-producing financial products, such as contracts and leases that are past the initial end term date, and that have not been renegotiated or extended, or, in other words, that have entered the “evergreen” period. Among other things, the method and computerized system of the present invention integrate processing of the “evergreen” contracts with a proprietary generalized ERP software product/solution such as Oracle™ E-Business suite's Lease Management system, and supplement the processing of regular contracts with the “evergreen” contract authoring and booking, processing, validation, billing, accounting, collections, modification and audit trailing of the changes made to the “evergreen” contract terms.
    Type: Grant
    Filed: May 2, 2007
    Date of Patent: February 5, 2013
    Assignee: Genpact Limited
    Inventors: Sridhar Moduga, Chandra Anupam, Prashant Gunjikar, Samir Singh, Uday Kumar
  • Publication number: 20130030778
    Abstract: Certain embodiments of the invention may include systems, methods, and apparatus for predicting impact on a pipeline delivery infrastructure. According to an example embodiment of the invention, a method is provided that can include simulating a pipeline delivery infrastructure; identifying one or more sections in the infrastructure; and forecasting an impact of the infrastructure based on one or more modifications to the infrastructure or on one or more new demand points wherein the forecasting comprises estimating pressures in each of identified one or more sections.
    Type: Application
    Filed: July 29, 2011
    Publication date: January 31, 2013
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Kavitha Andoji, Uday Kumar Dubasi, Ganesh Kumar Somesula
  • Publication number: 20120252897
    Abstract: An aqueous gel composition of the present invention comprising about 0.1 to 0.3 wt % adapalene and about 2.5 to 5.0 wt % benzoyl peroxide, as active ingredients, wherein both the active ingredients are stabilized in hydrophilic gelling matrix of pH dependent gelling agent comprising crosslinked, acrylic acid-based polymer(s).
    Type: Application
    Filed: March 23, 2012
    Publication date: October 4, 2012
    Applicant: Glenmark Generics Limited
    Inventors: Kamal Mehta, Lalatendu Panigrahi, Uday Kumar Nayak, Balakrishna Patro
  • Publication number: 20120238270
    Abstract: An apparatus and method for controlling access to a dual stack architecture using attention (AT) commands including establishing a first subscription to a first network; establishing a second subscription to a second network; selecting a desired subscription from the first subscription and second subscription; and sending an attention (AT) command to direct at least one of a plurality of existing attention (AT) commands towards the desired subscription.
    Type: Application
    Filed: March 16, 2011
    Publication date: September 20, 2012
    Applicant: QUALCOMM Incorporated
    Inventors: Uday Kumar Arava, Simi Anand Sathy, Nagarjuna Reddy Chaganti, Bhavik Kirit Shah
  • Patent number: 8221995
    Abstract: The present invention relates to methods and compositions for diagnosing SIRS, sepsis, severe sepsis, septic shock, or MODS in a subject, or assigning a prognostic risk for one or more clinical outcomes for a subject suffering from SIRS, sepsis, severe sepsis, septic shock, or MODS, the method comprising performing an immunoassay for CCL23 splice variant.
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: July 17, 2012
    Inventors: Seok-Won Lee, Kelline M. Rodems, David W. Oelschlager, Uday Kumar Veeramallu, Joseph A. Buechler, Paul H. McPherson
  • Publication number: 20120046457
    Abstract: The present application relates to processes for the preparation and purification of decitabine structurally represented by formula (I): and to processes for the preparation of a crystalline form of decitabine.
    Type: Application
    Filed: October 27, 2011
    Publication date: February 23, 2012
    Applicants: DR. REDDY'S LABORATORIES, INC., DR. REDDY'S LABORATORIES LTD.
    Inventors: Naveen Kumar Kolla, Uday Kumar Neelam, Sudhakar Reddy Baddam, Srinivas Gangula
  • Publication number: 20110314442
    Abstract: An example embodiment disclosed is a method for reducing parallelism of computer source code. The method includes receiving multi-threaded program source code and representing the multi-threaded program source code as a polyhedral framework stored in computer readable memory. The polyhedral framework is used to convert the polyhedral framework from the multi-threaded program source code representation to a single-threaded program source code representation.
    Type: Application
    Filed: June 17, 2010
    Publication date: December 22, 2011
    Applicant: International Business Machines Corporation
    Inventors: Uday Kumar Bondhugula, Alexandre E. Eichenberger, John Kevin P. O'Brien, Lakshminarayanan Renganarayana, Yuan Zhao
  • Publication number: 20110224102
    Abstract: The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences.
    Type: Application
    Filed: May 20, 2011
    Publication date: September 15, 2011
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Jeff Gray, Joe Buechler, Uday Kumar Veeramallu